Skip to main content
Premium Trial:

Request an Annual Quote

Friedrich von Bohlen, Christoph Mutter, Jan Traenckner, Jrgen Dormann, Klaus Pohle, Richard Roy, Claire Fraser, Steven Salzberg


Lion Bioscience last week appointed Friedrich von Bohlen, Christoph Mutter, and Jan Traenckner to its new supervisory board. The three replace J rgen Dormann, Klaus Pohle, and Richard Roy, who resigned from the supervisory board in October. Von Bohlen, who will serve as chairman, was formerly CEO of Lion and also serves as chairman of the board of Private Life BioMed in Frankfurt, Germany, and is on the board of Oncoscore in Basel, Switzerland. Mutter is a lawyer, certified public accountant, and tax advisor, and is currently chairman of the board at Balloon of Mannheim, Germany, vice chairman of the board at Huber Portfolio of Frankfurt, Germany, and a board member at StarCapital, also based in Frankfurt. Traenckner is the founder and CEO of VentureCheck, a private equity company based in Munich, Germany.

Claire Fraser, president of the Institute for Genomic Research, and Steven Salzberg, senior bioinformatics director, at TIGR, have been named as fellows of the American Association for the Advancement of Science, TIGR said last week.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.